SPP1 and colonic neoplasm: Furthermore, OPN monoclonal antibody MPIIIB10 delayed colon tumor growth and enhanced B cell-based vaccine-induced tumor growth suppression through inhibition of tumor OPN-induced myeloporesis [29].